J0712 HCPCS code: Injection, ceftaroline fosamil, 10 mg
J0712 is the HCPCS Level II code for injection, ceftaroline fosamil, 10 mg. In 2024 Medicare paid an average of $3.04 per service for J0712 across 42,341 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 180 per day on outpatient hospital claims. Medicare volume rose 49% from 2022 to 2024 (28,405 to 42,341 services). In 2024, about 26 clinicians billed Medicare for J0712 for 22 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2012-01-01 |
| Last action effective | 2016-01-01 |
Who bills J0712 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 26 |
| Medicare beneficiaries | 22 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0712, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 28,405 | 26 | $3.60 | $2.87 |
| 2023 | 22,073 | 16 | $3.76 | $2.99 |
| 2024 | 42,341 | 22 | $3.82 | $3.04 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 180 | Prescribing Information |
| practitioner claims | 120 | Prescribing Information |
What changed for J0712
- 2012-01-01: J0712 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0712?
J0712 is the HCPCS Level II code for injection, ceftaroline fosamil, 10 mg. Short descriptor: "Ceftaroline fosamil inj".
How much does Medicare pay for J0712?
In 2024, the average Medicare payment was $3.04 per service (average allowed $3.82).
Does Medicare cover J0712?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0712 can be billed per day?
180 on outpatient hospital claims; 120 on practitioner claims (NCCI medically unlikely edits).
Related J07 codes
- J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
- J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
- J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
- J0706 — Injection, caffeine citrate, 5 mg
- J0710 — Injection, cephapirin sodium, up to 1 gm
- J0713 — Injection, ceftazidime, per 500 mg
- J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g
- J0715 — Injection, ceftizoxime sodium, per 500 mg
- J0716 — Injection, centruroides immune f(ab)2, up to 120 milligrams
- J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0720 — Injection, chloramphenicol sodium succinate, up to 1 gm
- J0725 — Injection, chorionic gonadotropin, per 1,000 usp units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0712
- Watch J0712 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0712
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.